Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus

(2012) Justine Migdall-Wilson et al.   PLoS One

Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia

(2012) Jing Liu et al.   ACS Medicinal Chemistry Letters

Galectin-3 is a new MerTK-specific eat-me signal

(2011) Nora B. Caberoy et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

(2011) Ching-Hon Pui et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

(2011) Markus Pfirrmann et al.   LANCET ONCOLOGY

Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia

(2011) Steven M. Trifilio et al.   LEUKEMIA RESEARCH

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

(2011) Kim J. Png et al.   NATURE

Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology

(2011) A E J Rogers et al.   ONCOGENE

Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia

(2010) C. Muller-Tidow et al.   BLOOD

Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis

(2010) Nora B Caberoy et al.   EMBO JOURNAL

Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials

(2010) A Sander et al.   LEUKEMIA

MSK1 activation in acute myeloid leukemia cells with FLT3 mutations

(2010) T Odgerel et al.   LEUKEMIA

A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia

(2010) Anjali S. Advani et al.   LEUKEMIA RESEARCH

Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity

(2010) A. K. Keating et al.   MOLECULAR CANCER THERAPEUTICS

Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010

(2009) D. Pulte et al.   ANNALS OF ONCOLOGY

Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia

(2008) Chih-Chen Hong et al.   CANCER LETTERS

Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML

(2007) Anjali S. Advani et al.   LEUKEMIA RESEARCH